553 First-in-class inhibitors of ERAP1 alter the immunopeptidome of cancer, driving a differentiated T cell response leading to tumor growth inhibition

553 First-in-class inhibitors of ERAP1 alter the immunopeptidome of cancer, driving a differentiated T cell response leading to tumor growth inhibition

Bibliographic Details
Main Authors: Peter Joyce, Martin Quibell, Jason Shiers, Carmen Tong, Kristopher Clark, Nicola Ternette, Andrew Leishman, Kate Anderton, Jessica Sette, Wayne Paes
Format: Article
Language:English
Published: BMJ Publishing Group 2021-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items